From: Translational toxicology: a developmental focus for integrated research strategies
Disease/Indication | Treatment | Outcome | Selected references |
---|---|---|---|
Neural tube defects | Folate | Reduction in risk of neural tube defects | American Academy of Pediatrics Committee on Genetics [80] |
U.S. Preventive Services Task Force [81] | |||
Vision and cognitive function | Docosahexaenoic acid (DHA) | Support optimal visual and cognitive development | Koletzko et al. [82] |
Smoking | Nicotine and/or N-acetylcysteine (NAC) | Smoking cessation and/or chemoprevention of DNA (and other) damage | Coleman et al. [83] |
De Flora et al. [84] | |||
Van Schooten et al. [85] | |||
Maternal (and fetal)hypothyroidism | Thyroid hormone therapy | Avoid potential damage to neural development | Abalovich et al. [86] |
Rivkees & Mandel [87] | |||
Shields et al. [88] | |||
Kuppens et al. [89] | |||
Lazarus et al. [90] | |||
Cerebral palsy associated with preterm delivery | Magnesium sulfate (MgSO4) | Reduction in risk of cerebral palsy/ motor disorders in childhood | Nelson & Grether [91] |
Rouse et al. [92] | |||
Conde-Agudelo & Romero [93] | |||
Rouse [94] | |||
Doyle et al. [95] |